Search
for
Sort by
Research 91–120 of 1000+
- Hypertrichosis due to minoxidil
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Methotrexate in dermatology
- Alopecia areata after mogamulizumab treatment
- TERAPIA ORAL OU TÓPICA? REVISÃO INTEGRATIVA SOBRE O USO DE MINOXIDIL NA ALOPECIA ANDROGENÉTICA
- The use of ozonized sunflower oil in the treatment of wounds in small animals
- Adapalene–benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients
- Minoxidil.
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Skin Manifestations of Targeted Antineoplastic Therapy
- Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
- Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Psychotropic Medications and the Skin
- Cutaneous sarcoidosis post platelet‐rich plasma injections: A case report during the COVID pandemic
- Imported cutaneous Leishmaniasis in Japan
- Subacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapy
- Cutaneous reactions to recombinant cytokine therapy
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- PRIDE syndrome associated with panitumumab treatment – case report and literature review
- Cutaneous Manifestations of Lupus Erythematosus
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Polymeric Micelle Nanocarriers for the Cutaneous Delivery of Tacrolimus: A Targeted Approach for the Treatment of Psoriasis
- Ketoconazole in cutaneous leishmaniasis
- INTERFERONS IN DERMATOLOGY
- CUTANEOUS T-CELL LYMPHOMA
- Immunomodulators in the treatment of cutaneous lymphoma